“Symptoms, diagnosis, treatment, and side effects of therapies are mostly based on data collection from male subjects. Since the processing systems access these studies and the guidelines based on them, the gender bias can be enhanced.

Therefore, gender-specific data must be considered during the planning stage for digital applications” states Dr. Berit Hippe, CEO of HealthBioCare. The basis must be fair data, that represent the general population and consider gender medicine.